Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,779 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Follow-Up Questions
¿Quién es el CEO de Takara Bio Inc?
Mr. Koichi Nakao es el President de Takara Bio Inc, se unió a la empresa desde 2007.
¿Qué tal es el rendimiento del precio de la acción TKBIF?
El precio actual de TKBIF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Takara Bio Inc?
Takara Bio Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Takara Bio Inc?
La capitalización bursátil actual de Takara Bio Inc es $NaN
¿Es Takara Bio Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para Takara Bio Inc, incluyendo 1 fuerte compra, 3 compra, 4 mantener, 0 venta, y 1 fuerte venta
